Avelios, Helios and the HIS Opportunity

From kma Online (translated, emphasis mine):

Within just a few months, Avelios Medical has achieved its second major upset in the German HIS market. Following its partnership with SAP, the young Munich-based HIS provider has now also entered into a strategic partnership with Fresenius. Fresenius, with its German hospital subsidiary Helios (more than 80 hospitals) and its Spanish subsidiary Quirónsalud (57 hospitals), operates the largest hospital network in Europe. The DAX-listed medical technology and healthcare group is now investing a multi-million euro sum in the up-and-coming HIS company.

The article continues:

According to kma, Helios currently relies primarily on two HIS solutions. Its Spanish subsidiary, Quirónsalud, uses "Casiopea." In Germany, the country's largest hospital chain largely uses IS-H. However, since official support for the SAP system ends in 2030, Fresenius needs alternatives, at least for its German hospitals. In this context, the group's investment in Avelios is "a strong signal," says manager Albrecht.

Avelios is a university spin-off that launched in 2020 and only 6 years later is already making considerable progress in arguably one of the most difficult markets for new entrants - hospital information systems (HIS). This is no coincidence: Both SAP and Fresenius are strategic investors, which now also step in as major international partners/customers. Changing the HIS of a hospital is a major decision that bears very high switching costs but as a private company Fresenius can afford to plan with a longer horizon and invest more flexibly. That may have made it easier for Avelios but it surely didn’t make it easy - the road to spin-off is long and filled with challenges, especially in Germany, getting this far this quickly is worthy of respect.

That being said, timing is important in its own right and the fact that SAP is retiring their HIS system is a huge opportunity which Avelios was perfectly positioned to take advantage of. Now SAP has secured itself a place in the AI race and Avelios has gained access to a considerable network of potential customers. Is the game over for other HIS providers? How is AI changing the value chain? How will the business model change and are we going to see fresh blood entering and dominating the system? I’m excited to observe and analyse all of this here.

Healthcare Demand Drivers

This is the third point I want to address as part of my effort to explore the capacity constraints in the German healthcare system. Part one was looking at cost of care and part two from yesterday was about the origins of the physicians shortages in Germany. 200 years ago

Clinicians Shortages, Drivers

To continue the cost of care thread from yesterday, the second big capacity constraint is around clinicians. Here is a quick recipe for how to think about this problem: 1. First we take specialists such as radiologists and dermatologists (in-patient care) vs GPs (out-patient care). 2. Second we

Cost of Care Drivers

Last week I listed what I believe are the main factors contributing to capacity constraints in the healthcare system in Germany. Some of those are being already addressed in various ways, while others remain an open field (or shall we call it a blue ocean?): * Reimbursement incentives: Until recently, hospitals

Capacity Constraints

There are three main problems with the healthcare system in Germany: 1. Bad economics: cost of care is too high. This is driven by many factors, including reimbursement incentives, high manual work, various system inefficiencies and silos, and the medical field simply developing further and finding ever more cures for

Read more

Healthcare Demand Drivers

Clinicians Shortages, Drivers

Cost of Care Drivers

Capacity Constraints